Left Menu
Development News Edition

Lonza confident of 2020 target for Moderna COVID-19 vaccine supply

There is no approved COVID-19 vaccine yet, but several are in advanced trials, including from Pfizer Inc, Johnson & Johnson and Moderna, whose candidate relies on technology never previously approved that enlists human cells to help trigger an immune response. Torsten Schmidt, who heads Lonza's Visp facility, where Moderna's $210 million production lines are about 50% completed, said he has secured the equipment needed to avoid any last-minute setbacks.

Reuters | Updated: 30-09-2020 14:28 IST | Created: 30-09-2020 14:02 IST
Lonza confident of 2020 target for Moderna COVID-19 vaccine supply
Representative image Image Credit: ANI

Lonza is confident that U.S. and Swiss plants it is building to help make Moderna's COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.

New production lines at Lonza's site in Portsmouth, New Hampshire, aim to start making vaccine ingredients in November, while three lines in Visp, deep in a valley in the Swiss Alps - to supply 300 million vaccine doses annually - should begin delivering by December. There is no approved COVID-19 vaccine yet, but several are in advanced trials, including from Pfizer Inc, Johnson & Johnson and Moderna, whose candidate relies on technology never previously approved that enlists human cells to help trigger an immune response.

Torsten Schmidt, who heads Lonza's Visp facility, where Moderna's $210 million production lines are about 50% completed, said he has secured the equipment needed to avoid any last-minute setbacks. "The delivery of the equipment was critical," Schmidt said in an interview. "You typically wait 12 months, you're talking here about 4-5 months. In the end, the CEO has been talking to the CEOs of suppliers, to get the equipment delivered."

Lonza, whose shares are up 60% this year, has a 10-year contract to supply ingredients to Moderna, including for up to 1 billion doses annually of COVID-19 vaccine. The ingredients include a synthetic version of messenger RNA (mRNA), genetic material, which is packed inside tiny fat droplets called nanolipids, to instruct human cells to make a non-replicating form of the coronavirus's spike protein and trigger an immune response in the body.

They will be frozen at -70 degrees Celsius, then shipped from Visp to Spain's Laboratorios Farmacéuticos Rovi SA for "fill and finish," the final stage of manufacture. STILL HIRING

Lonza is still hiring some of the roughly 200 workers it needs to operate the Moderna production lines in Visp, located where the Alps tip up towards the nearby ski towns of Zermatt, near the famed Matterhorn, and Saas Fe. In all, Lonza expects to have some 4,000 workers in Visp by January, from 3,500 now, following a hiring spree fueled by its manufacture of drugs for other customers, as well as Moderna. They include Roche, Sanofi and California's Humanigen, with which it has partnered on another COVID-19 project.

However ready Lonza is, when precisely Moderna's vaccine becomes available depends on its trials and regulators. The U.S. company has said about 20 million doses should be ready by the year's end. Already Lonza's drugs unit revenue has seen double-digit percentage gains, prompting the Basel-based company earlier this year to seek to offload its $1.8 billion-per-year speciality chemicals business, after sales of products, such as animal feed supplements and resins have stagnated.

Talks with potential buyers are ongoing, Renzo Cicillini, Lonza's Visp site head, said. 'A LITTLE PROUD'

In Visp, two hours by train from both Zurich and Milan, Italy, its roughly 8,000 residents are accustomed to Lonza's taking a behind-the-scenes role in making drugs for better-known companies, the town's mayor, Niklaus Furger, said. But the COVID-19 pandemic, which has killed more than 1 million people and wreaked global economic havoc, has left the people of Visp hoping for success that would put it on the map.

"The idea that a vaccine might just be produced in Visp with which we could fight against the pandemic, that would be excellent," Furger told Reuters at Visp city hall. "For certain, the attention of the world would be trained on Visp along with Lonza, something that admittedly would make us all a little proud."


TRENDING

OPINION / BLOG / INTERVIEW

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Guinea’s elections hearken back to the autocracy and violence of its past

... ...

Videos

Latest News

China launches crackdown on mobile web browsers, decries 'chaos' of information

Chinas top cyber authority said on Monday it would carry out a rectification of Chinese mobile internet browsers to address what it called social concerns over the chaos of information being published online.Chinas strict internet censorshi...

South Korea economy returns to growth in Q3 as stimulus kicks in

South Koreas economy returned to growth in the third quarter, recovering from its sharpest contraction in more than a decade, as the government pushed through stimulus measures and major trading partners eased coronavirus pandemic restricti...

Third US-India 2+2 dialogue holds significance as defence agreements would be signed says Jaishankar

Dhruva Jaishankar, Director of the U.S. Initiative at the New Delhi-based Observer Research Foundation ORF on Monday local time said that the significance of the third India-US 22 Ministerial Dialogue is significant as a number of defence a...

Facebook launches free-to-play cloud games in official app, web

Facebook has ventured into the cloud gaming market with the launch of several cloud-streamed games in the Facebook app and on the browser as well.The social media giant noted that it is not spinning off a separate cloud gaming service, inst...

Give Feedback